Join
Live feed
·
INSIDERFilingvia Quantisnow
Kura Oncology Inc. logo

SVP, Finance & Accounting Doyle Thomas James sold $48,361 worth of shares (4,607 units at $10.50), decreasing direct ownership by 3% to 142,428 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KURA (Kura Oncology Inc.) and more on Quantisnow.